TOTAL VOLUME:
$134.1b
24H VOL:
$133,388,117
24H TRANSACTIONS:
2,388,728,490
OPEN INTEREST:
$1,436,095,462
405,232
Markets across
30,526
events
MATCHED EVENTS:
2,693
PLATFORM COVERAGE:
5
Polymarket:
39%
VS.
Kalshi:
61%
Closed: Aug 31, 7:59 PM EST
Predict
This market will resolve to “Yes” if the official closing price for Moderna, Inc. (MRNA) on Monday, August 31, 2026 (ET) is higher than $130.00. Otherwise, this market will resolve to “No”. If the Official closing price is exactly $130.00, this market will resolve to 50-50 If Nasdaq does not hold a regular trading session on August 31, 2026, the final completed Nasdaq trading session in August 2026 will be used. If Moderna, Inc, (MRNA) does not trade at all during the relevant regular session, this market will resolve 50-50. If the session is shortened, the official closing price published for that shortened session will still be used for resolution. If the relevant trading session has no official closing price (for example, due to a trading halt into the market close, system issue, delisting, or other disruption), the market will use the last valid on-exchange trade price of the regular session as the effective closing price. The resolution source for this market is Yahoo Finance, specifically the Moderna, Inc. (MRNA) “Close” price published under Historical Data at https://finance.yahoo.com/quote/MRNA/history/. In the event of a stock split, reverse stock split, or similar corporate action affecting Moderna, Inc. (MRNA) during the listed time frame, this market will resolve based on split-adjusted prices as displayed on Yahoo Finance. If Yahoo Finance is unavailable or does not publish a Close price for MRNA by September 4th, the official closing price reported by Nasdaq will be used. However a consensus of credible reporting may also be used.
This market will resolve to “Yes” if the official closing price for Moderna, Inc. (MRNA) on Monday, August 31, 2026 (ET) is higher than $130.00. Otherwise, this market will resolve to “No”. If the Official closing price is exactly $130.00, this market will resolve to 50-50 If Nasdaq does not hold a regular trading session on August 31, 2026, the final completed Nasdaq trading session in August 2026 will be used. If Moderna, Inc, (MRNA) does not trade at all during the relevant regular session, this market will resolve 50-50. If the session is shortened, the official closing price published for that shortened session will still be used for resolution. If the relevant trading session has no official closing price (for example, due to a trading halt into the market close, system issue, delisting, or other disruption), the market will use the last valid on-exchange trade price of the regular session as the effective closing price. The resolution source for this market is Yahoo Finance, specifically the Moderna, Inc. (MRNA) “Close” price published under Historical Data at https://finance.yahoo.com/quote/MRNA/history/. In the event of a stock split, reverse stock split, or similar corporate action affecting Moderna, Inc. (MRNA) during the listed time frame, this market will resolve based on split-adjusted prices as displayed on Yahoo Finance. If Yahoo Finance is unavailable or does not publish a Close price for MRNA by September 4th, the official closing price reported by Nasdaq will be used. However a consensus of credible reporting may also be used.
On Predict, the odds for this market reflect aggregated trader expectations, which can diverge from traditional analyst forecasts. While analysts may issue target prices or reports influencing investor sentiment, prediction market odds capture real-time betting behavior. Traders might price in different risks or near-term catalysts than consensus analyst views, making this market an alternative signal to consider alongside expert opinions.
On Predict, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. On Predict, this market is priced through a decentralized process where traders buy and sell contracts based on their outlook for Moderna’s price. The current top outcome’s percentage chance is set by the balance of these bets, with volume of $2,333 indicating liquidity. Price fluctuations happen continuously as new information emerges, shaping the market’s outlook.
This market resolves around Aug 31, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. The final stock price at the close of trading on that day will determine whether the contract settles as yes or no.
Several signals could shift this market before Aug 31, 2026. Earnings reports, FDA decisions, or major partnership announcements for Moderna may cause rapid price adjustments. Broader market trends, sector performance, or macroeconomic factors like interest rate changes can also influence trader sentiment. Any surprise news that impacts Moderna’s stock price has the potential to move this market significantly as traders react.